These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 385880)

  • 21. Increase in the in vitro susceptibility of Staphylococcus aureus to antimicrobial agents in the presence of Candida albicans.
    deRepentigny J; Lévesque R; Mathieu LG
    Can J Microbiol; 1979 Apr; 25(4):429-35. PubMed ID: 385127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological changes in yeasts as a result of the action of 5-fluorocytosine.
    Arai T; Mikami Y; Yokoyama K; Kawata T; Masuda K
    Antimicrob Agents Chemother; 1977 Aug; 12(2):255-60. PubMed ID: 332075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
    Lynch ME; Sobel JD
    J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel synthetic anti-fungal tripeptide effective against Candida krusei.
    Gill K; Kumar S; Xess I; Dey S
    Indian J Med Microbiol; 2015; 33(1):110-6. PubMed ID: 25560012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH; Sarosi GA
    Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of three methods for in vitro susceptibility testing of Candida species with flucytosine.
    Moore CB; Walls CM; Denning DW
    J Antimicrob Chemother; 2003 Feb; 51(2):297-304. PubMed ID: 12562694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A
    Chemotherapy; 1978; 24(1):2-16. PubMed ID: 338264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine.
    Auger P; Dumas C; Joly J
    J Infect Dis; 1979 May; 139(5):590-4. PubMed ID: 374653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans.
    Di Vito M; Podo F; Torosantucci A; Carpinelli G; Whelan WL; Kerridge D; Cassone A
    Antimicrob Agents Chemother; 1986 Feb; 29(2):303-8. PubMed ID: 3521476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
    Rumler W; Heins S; Heins J
    Mykosen; 1984 Sep; 27(9):436-42. PubMed ID: 6390193
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of two antifungal susceptibility testing of Candida sp. isolates using agar diffusion method: Neo-sensitabs® tablets and Bio-rad® disks.
    Uwingabiye J; Iken M; Zohoun AG; Boumhil L; Lemkhente Z; Naoui H; Bouchrik M; Lmimouni B
    J Mycol Med; 2016 Mar; 26(1):61-5. PubMed ID: 26471055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
    Polak A; Wain WH
    Chemotherapy; 1977; 23(4):243-59. PubMed ID: 324722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
    Guinet R
    Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility and resistance of Candida to 5-fluorocytosine in relation to the cell wall ultrastructure.
    Montplaisir S; Nabarra B; Drouhet E
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1028-32. PubMed ID: 945713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sensitivity of yeasts against 5 fluorocytosine. Comparison of five methods (author's transl)].
    Brinkmann F
    Z Hautkr; 1981 Oct; 56(19):1255-63. PubMed ID: 7032101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel antifungal nonapeptide generated by combinatorial approach.
    Kumar M; Chaturvedi AK; Kavishwar A; Shukla PK; Kesarwani AP; Kundu B
    Int J Antimicrob Agents; 2005 Apr; 25(4):313-20. PubMed ID: 15784311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
    Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
    J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.